Related Experiment Video
Updated: Apr 5, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Central-Variant Posterior Reversible Encephalopathy due to Sulfasalazine: A Case Report
Levent Ocek1, Ufuk Sener, Burcu S Demirtas
1Clinic of Neurology, Tepecik Education and Research Hospital, Izmir, Turkey.
Objective:
To report a rare case with central-variant posterior reversible encephalopathy syndrome due to sulfasalazine.
Clinical Presentation And Intervention:
A 55-year-old female patient presented with seizure and acute-onset hemiparesia. Thirty days earlier, treatment with sulfasalazine was commenced in response to a diagnosis of psoriatic arthritis. Laboratory examinations were normal. Brain magnetic resonance imaging showed symmetric edema within basal ganglia and thalami with sparing of the cerebral cortices. After stopping the treatment of sulfasalazine, clinical and radiological findings regressed dramatically.
Conclusion:
This was a case of central-variant posterior reversible encephalopathy syndrome due to sulfasalazine, and atypical imaging findings should be kept in mind for early diagnosis.
More Related Videos
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024